Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Tetra Bio Pharma Inc TBPMQ

Healthcare Cannabis
Tetra Bio-Pharma Inc. is a Canada-based cannabinoid-derived drug discovery and development company. The Company has developed a pipeline of cannabinoid-based drug products for a range of medical conditions, including pain, inflammation, and oncology. The Company has a pipeline of formulations and drug delivery systems with a portfolio of assets from the early research and development phase to... see more

Recent & Breaking News (GREY:TBPMQ)

Tetra Bio-Pharma Adds Two Board Members and Appoints New COO

Accesswire September 17, 2020

Tetra Bio-Pharma Appoints Chief Financial Officer

Accesswire September 11, 2020

Dania Scott Joins Tetra Bio-Pharma as Senior Vice President Commercial Strategy

Accesswire September 4, 2020

Tetra Bio-Pharma Announces Plenitude Clinical Trial is Initiated

Accesswire September 2, 2020

Tetra Bio-Pharma Announces Data on its CBD Metabolite Study in Humans

Accesswire August 27, 2020

Tetra Bio-Pharma Engages Dalton Pharma for GMP Manufacturing of ARDS-003

Accesswire August 18, 2020

Tetra Bio-Pharma and Mondias Enter Into Final Agreement For The Purchase Of Lumiera Health Innovation Inc.

Accesswire August 17, 2020

Tetra Bio-Pharma Virtually Opens the Market

Accesswire August 7, 2020

CORRECTION FROM SOURCE: Tetra Bio-Pharma Provides Update on QIXLEEF(TM)'s European Activities

Accesswire August 6, 2020

Tetra Bio-Pharma Provides Update on QIXLEEF(TM)'s European Activities

Accesswire August 6, 2020

49 Public Companies to Present at the SNN Network Virtual Conference on August 3-6, 2020

Accesswire August 3, 2020

Tetra Bio-Pharma Announces Expected Effective Date of Listing on TSX of its Common Shares and Warrants

Canada NewsWire July 30, 2020

Tetra Bio-Pharma's Management Provides Corporate Update on QIXLEEF(TM) & CAUMZ(TM) Drug Development Activities

Accesswire July 28, 2020

Tetra Bio-Pharma Provides Management Update on Pharma Focus

Accesswire July 27, 2020

FDA Provides Positive Feedback on Tetra Bio-Pharma's Pre-Investigational New Drug Application for ARDS-003 to Be Studied in COVID-19 Patients at Risk of Developing Acute Respiratory Distress Syndrome (ARDS)

Accesswire July 16, 2020

Tetra Bio-Pharma Receives Conditional Approval to Graduate to the TSX

Accesswire July 15, 2020

Tetra Bio-Pharma Appoints Steve Edgett As A Strategic Advisor

Accesswire July 9, 2020

Tetra Bio-Pharma Announces Stock Option Grant

Accesswire June 25, 2020

Proactive Virtual Event Showcases Four Rising Stars of the Life Sciences Industry

GlobeNewswire June 22, 2020

Tetra Bio-Pharma Discusses the Potential of Their ARDS-003 Drug in the Fight Against COVID-19 with the Stock Day Podcast

Newsfile June 22, 2020